⌘K

Login Start Free

Home/Filings/4/0001470831-25-000392

4//SEC Filing

Apuli Maricel 4

Accession 0001470831-25-000392

CIK 0001743881other

View on SEC.gov Company Profile

Filed

Dec 9, 7:00 PM ET

Accepted

Dec 10, 7:53 AM ET

Size

4.8 KB

Accession

0001470831-25-000392

Insider Transaction Report

Form 4

Period: 2025-12-08

BridgeBio Pharma, Inc.BBIO

Chief Accounting Officer

Transactions

Sale
Common Stock
2025-12-08$74.26/sh−2,000$148,520→ 130,297 total

Footnotes (1)

[F1]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on September 8, 2025.

Documents

1 file

4
wk-form4_1765371229.xmlPrimary
FORM 4

Issuer

BridgeBio Pharma, Inc.

CIK 0001743881

Entity typeother

Related Parties

1

filerCIK 0002058197

Filing Metadata

Form type: 4
Filed: Dec 9, 7:00 PM ET
Accepted: Dec 10, 7:53 AM ET
Size: 4.8 KB

View on SEC.gov